Singapore markets closed

LifeStance Health Group, Inc. (LFST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.57-0.18 (-2.32%)
At close: 04:00PM EST
7.57 0.00 (0.00%)
After hours: 04:31PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 3.47B
Enterprise value 3.41B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.25
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-65.43%
S&P500 52-week change 314.07%
52-week high 329.81
52-week low 37.45
50-day moving average 39.25
200-day moving average 315.50

Share statistics

Avg vol (3-month) 31.13M
Avg vol (10-day) 31.08M
Shares outstanding 5374.15M
Implied shares outstanding 6N/A
Float 871.67M
% held by insiders 115.58%
% held by institutions 178.55%
Shares short (30 Dec 2021) 44.86M
Short ratio (30 Dec 2021) 43.78
Short % of float (30 Dec 2021) 45.67%
Short % of shares outstanding (30 Dec 2021) 41.30%
Shares short (prior month 29 Nov 2021) 44.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin -34.36%
Operating margin (ttm)-28.31%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)595.64M
Revenue per share (ttm)0.57
Quarterly revenue growth (yoy)70.50%
Gross profit (ttm)97M
EBITDA -118.5M
Net income avi to common (ttm)-514.65M
Diluted EPS (ttm)-0.49
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)212.12M
Total cash per share (mrq)0.57
Total debt (mrq)158.77M
Total debt/equity (mrq)10.28
Current ratio (mrq)3.12
Book value per share (mrq)4.13

Cash flow statement

Operating cash flow (ttm)-17.05M
Levered free cash flow (ttm)N/A